Format

Send to

Choose Destination
Genet Med. 2019 Apr 26. doi: 10.1038/s41436-019-0506-1. [Epub ahead of print]

Correction: Mitochondrial oxodicarboxylate carrier deficiency is associated with mitochondrial DNA depletion and spinal muscular atrophy-like disease.

Author information

1
Wellcome Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK.
2
Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK.
3
Wellcome Centre for Mitochondrial Research, Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
4
Leibniz Institute of Analytic Sciences (ISAS), Dortmund, Germany.
5
UVic-Genome BC Proteomics Centre, Vancouver, BC, Canada.
6
Department of Paediatric Neurology, Royal Victoria Infirmary, Newcastle upon Tyne Foundation Hospitals NHS Trust, Newcastle upon Tyne, UK.
7
Institute for Ageing and Health, Newcastle University, Newcastle upon Tyne, UK.
8
Institute of Neuroscience, Newcastle University, Newcastle upon Tyne, UK.
9
Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
10
Medical Research Council Mitochondrial Biology Unit, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK. ek@mrc-mbu.cam.ac.uk.
11
Wellcome Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, UK. rita.horvath@ncl.ac.uk.

Abstract

This Article was originally published under Nature Research's License to Publish, but has now been made available under a [CC BY 4.0] license. The PDF and HTML versions of the Article have been modified accordingly.

PMID:
31028354
DOI:
10.1038/s41436-019-0506-1

Supplemental Content

Full text links

Icon for Nature Publishing Group
Loading ...
Support Center